معرفی
Tomas Olsson is a Professor of Neurology at the Department of Clinical Neuroscience, Karolinska Institutet. His research focuses on identifying genetic and environmental risk factors for multiple sclerosis (MS), including interactions between genetic predisposition, viral infections (e.g., Epstein-Barr virus), and lifestyle factors such as smoking, obesity, and diet. He leads the Clinical Neuroimmunology and Immunomodulation research group under Fredrik Piehl's program.
Education: Docent (1985) from Karolinska Institutet. Current roles include Senior Professor (2024–2025) and previous Professorship (2020–2024). Affiliations include the Karolinska University Hospital Solna and the Clinical Neuroimmunology unit.
Research interests emphasize MS pathogenesis, biomarker discovery, and translational immunology. Key areas include viral triggers (HHV-6A, EBV), metabolic dysfunction, and the role of B-cells in autoimmunity. His work bridges basic science and clinical applications, addressing disease progression and disability outcomes.
Publications (2023–2025) highlight studies on EBV antibody reactivity, bile acid metabolism in MS, and genetic loci influencing disease severity. Collaborations span immunology, genomics, and ancient DNA analysis to unravel MS complexity.
